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phagocytosis [2]; therefore, we analyzed whether Rho-Edgbaston
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ing ROK-KD (Table 1). We also used Y-27632, which is
an inhibitor of the kinase activity of ROK, although it
can also inhibit PRK2 [9, 10]. Cells treated with Y-27632
also showed reduced efficiency of internalization (TableSummary
1), although neither particle binding (Figure S1A) nor
overall actin morphology were affected (Figure 1Aa andPhagocytosis through Fc receptor (FcR) or comple-
data not shown). Together, these data indicate that ROKment receptor 3 (CR) requires Arp2/3 complex-medi-
activity plays an important role in CR-mediated phago-ated actin polymerization, although each receptor
cytosis.uses a distinct signaling pathway [1]. Rac and Cdc42
We analyzed whether ROK was also involved in FcR-are required for actin and Arp2/3 complex recruitment
mediated phagocytosis in J774.A1 cells. Inhibition ofduring FcR phagocytosis, while Rho controls actin
ROK, either by expression of ROK-KD or Y-27632 treat-assembly at CR phagosomes [2, 3]. To better under-
ment, caused no difference in the general actin morphol-stand the role of Rho in CR phagocytosis, we tested
ogy (Figure 1Ba and data not shown), particle bindingthe idea that a known target of Rho, Rho-kinase (ROK),
(data not shown), or internalization compared to un-might control phagocytic cup formation and/or en-
treated cells (Table 1). Thus, the requirement for ROKgulfment of particles. Inhibitors of ROK (dominant-
activity seems to be specific to CR-mediated phagocy-negative ROK and Y-27632) and of the downstream
tosis.target of ROK, myosin-II (ML7, BDM, and dominant-
negative myosin-II), were used to test this idea. We
found that inhibition of the Rho → ROK → myosin-II
Myosin-II Is Recruited to CR Phagosomespathway caused a decreased accumulation of Arp2/3
during Phagocytosiscomplex and F-actin around bound particles, which
The requirement for ROK in CR phagocytosis suggestsled to a reduction in CR-mediated phagocytic en-
that its downstream target, myosin-II [7, 11], may alsogulfment. FcR-mediated phagocytosis, in contrast,
be involved. Two nonmuscle myosin-II isoforms are ex-was independent of Rho or ROK activity and was only
pressed in mammalian cells [12, 13]; however, blooddependent on myosin-II for particle internalization, not
cells only express myosin-IIA (Figure S2 in the Supple-for actin cup formation. While myosins have been pre-
mentary Material available with this article online andviously implicated in FcR phagocytosis [4–6], to our
[14]). Myosin-IIA localization was observed on both CRknowledge, this is the first demonstration of a role for
and FcR phagosomes in J774.A1 cells (Figures 2 andmyosin-II in CR phagocytosis.
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not shown), nor did they affect particle binding (FiguresTable 1. Efficiency of Internalization in CR or FcR Phagocytosis
S1B–S1C). However, the efficiency of CR-mediated
CR Internalization (Percentage of Control) phagocytosis in treated cells was reduced compared
J774.A1 Cos-7 with that in untreated cells (Table 1). ML7 also reduced
the efficiency of internalization for FcR phagocytosisControl 100 100
(Table 1), which is consistent with previous data for BDMMyc-ROK-K 135  28 110  22
[4, 5]. These results confirm the role of myosin-II duringn  3 n  3
Myc-ROK-KD 27  14** 41  29** FcR-mediated phagocytosis. Importantly, our data
n  3 n  3 now suggest a role for myosin-II activity in the CR-
Y-27632 61  14** 60  20 dependent phagocytic pathway.
n  9 n  2
Since these inhibitors may have a broader specificityML7 61  9** 30  6
than previously recognized [17], we also used a domi-n  9 n  2
nant-negative fragment of the nonmuscle myosin-IIABDM 42  18** 45  2
n  9 n  2 heavy chain. This construct, lacking amino acids 1–591
GFP-Myosin-IIA 127  6** 100  17 (N592), has lost its abilities to bind ATP and actin (even
n  3 n  4 though actin binding sequences are still present) but is
GFP-N592 69  15** 65  4**
still able to assemble myosin filaments, thereby inhib-n  3 n  4
iting contractility [18]. GFP-myosin-IIA or GFP-N592
FcR Internalization (Percentage of Control) were expressed in Cos-7 cells. We assayed phagocyto-
J774.A1 Cos-7 sis at the time point at which the expression levels of
GFP-N592 were sufficient to disrupt stress fibers, butControl 100 100
cell rounding had not yet taken place, i.e., 20–24 hrMyc-ROK-K 130  6 n.d.
[18]. None of the myosin-II constructs affected par-n  2
Myc-ROK-KD 111  40 n.d. ticle binding (data not shown). However, GFP-N592-
n  2 expressing cells showed a reduced ability to internalize
Y-27632 118  20 n.d. through either the FcR or the CR when compared to
n  3
control cells or GFP-myosin-IIA-expressing cells (TableML7 60  17** n.d.
1). The inhibitory effect of GFP-N592 on CR-mediatedn  6
phagocytosis was also observed in microinjectedBDM [4] n.d.
GFP-Myosin-IIA n.d. 100  31 J774.A1 macrophages (Table 1). In contrast to ROK-KD
n  5 and BDM, which appear to block CR phagocytosis, GFP-
GFP-N592 n.d. 69  28** N592, ML7, and Y-27632 all seem to delay the CR
n  5
phagocytic process (time-course experiments in Fig-
J774.A1 or Cos-7 cells were transferred to HEPES-containing se- ures S2A–S2C and S3 and data not shown). This could
rum-free medium (SFM-H) for 3 hr prior to the phagocytosis assay. suggest that either other pathways downstream of Rho
After microinjection, transfection, or drug treatment, opsonized par-
might play a role in CR phagocytosis or, more likely, thatticles were resuspended in SFM-H and were added to the cells at
the inhibitors are not completely effective in blocking37oC for 15 min. For CR-mediated phagocytosis, J774.A1 cells were
protein function. Nevertheless, our data indicate thatfirst incubated with 150 ng/ml phorbol 12-myristate 13-acetate
(PMA) for 15 min to induce CR activation [29]. Particles were stained myosin-IIA is involved in particle internalization during
as described previously [2, 3]. Particle binding was quantified by both CR- and FcR-mediated phagocytosis.
counting ten fields of phagocytic cells in duplicate for each condition
in each experiment and did not vary compared with the respective
controls (see Figure S1 in the Supplementary Material for titration Myosin-II Is Required for Actin Cupassays). Internalization of particles was counted as the number of
Assembly during CR, but Notinternalized particles per 100 bound particles. The statistical signifi-
FcR, Phagocytosiscance of these data was tested using a paired Student’s t test with
a goodness-of-fit of p  0.05 (*) or p  0.01 (**). The results are Since both CR and FcR phagocytosis appear to use
expressed as the percentage of internalization in cells under dif- myosin-IIA activity for particle engulfment, we examined
ferent conditions compared with internalization of their respective whether ROK and MLCK directed myosin-IIA recruit-
controls (percentage of control) and are the mean of “n” experi-
ment to the phagosome. Therefore, we quantified thements  the standard deviation.
percentage of phagocytic cups that were positive for
myosin-IIA in control cells and in cells treated with ROK
and MLCK inhibitors. ML7 prevented the recruitment of
myosin-IIA to both CR and FcR phagosomes, whileMyosin-II Plays a Role in Particle
Internalization during Both CR- Y-27632 inhibited myosin-IIA recruitment to CR phago-
somes (Table 2). Y-27632 had no effect on FcR uptakeand FcR-Mediated Phagocytosis
Myosin-II activity controls FcR-mediated phagocytosis (Table 1); therefore, we did not analyze its involvement
in FcR recruitment in any more detail.[4, 5]. To determine whether myosin-II was also required
for CR phagocytosis, we made use of two chemical Since Rho activity is required for the recruitment of
Arp2/3 complex and actin filaments to the phagocyticinhibitors: ML7, which inhibits myosin light chain kinase
(MLCK) [15], and BDM, previously described to block the cup during CR phagocytosis [3], we hypothesized that
ROK and myosin-II might be part of this pathway. WeATPase activity of myosin-II [16]. None of the inhibitors
affected the overall actin morphology of the cells at the observed that cells treated with Y-27632, ML7, or BDM
showed a significantly reduced number of particles ac-concentrations used (Figures 1Aa and 1Ba and data
Figure 1. F-Actin and Arp2/3 Complex Recruitment to Phagosomes in Cells Treated with ROK and MLCK Inhibitors
(A and B) Macrophages were incubated with Y-27632 or ML7 prior to the (A) CR or (B) FcR phagocytic assay. Cells were stained for (a)
F-actin and (b) RBC (merged in [b], F-actin in red, and RBC in green) or (c) Arp2/3 complex and (d) RBC (merged in [d], Arp2/3 complex in
green, and RBC in red). Arrows indicate the recruitment of F-actin or Arp2/3 complex to phagosomes. (A) Note that, in CR phagocytosis,
there is a reduced number of internalized RBC and a reduced recruitment of actin and Arp2/3 complex to phagosomes, in cells treated with
Y-27632 or ML7. (B) In contrast, during FcR phagocytosis, treatment with ML7 cells only reduced internalization and had no effect on the
recruitment of actin or Arp2/3 complex. The scale bars represent 10 m.
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Figure 2. Localization of Myosin-IIA to the CR Phagosome during the Different Stages of Internalization
CR phagocytosis was assayed, and macrophages were stained for external beads (prior to permeabilization, red) and myosin-IIA (green,
bottom panel). Merged images are shown in the top panel. Stages 0–4 are defined as follows: (0) particle is bound, but no cup is visible; (1–2)
a fraction of the particle is still outside the cell; (3–4) the particle is inside the cell, near the periphery (indicating possible recent entry) (3), or
near the center of the cell (4). Myosin-IIA is localized to the cup in stages 1–3. Stage 0 is typically observed at the beginning of the experiment;
by 5–20 min, stages 1–3 were predominant, while stage 4 was observed almost exclusively in cells left for 60 min or more. A bead is 3 m
in diameter.
cumulating Arp2/3 complex or F-actin at phagocytic trast, ROK does not appear to be involved in FcR
phagocytosis. In the FcR pathway, inhibition of MLCKcups during CR phagocytosis (Figure 1A and quantified
caused a significant reduction of both myosin-IIA local-in Table 2). On the contrary, ML7 did not affect the
ization and particle uptake, while it did not affect actinrecruitment of these proteins to FcR-dependent
or Arp2/3 complex recruitment, suggesting a role forphagosomes (Figure 1B and Table 2), which is consis-
MLCK and myosin-IIA in later steps of phagosome for-tent with previous data for BDM [4].
mation, after the actin cup has assembled, in agreementOur observations, combined with those of other labs,
with previous findings [4, 5]. Our data implicate MLCKare summarized in Figure 3. ROK and MLCK contribute
and/or the regulation of myosin-II activity during actinto the localization of myosin-IIA, actin assembly, and
assembly at CR phagosomes and possibly during theparticle engulfment during CR phagocytosis. In con-
closure of FcR phagosomes. This contrasts with pub-
lished observations in which phagocytosis of IgG-opso-
Table 2. Efficiency of Myosin-II, F-Actin, and Arp2/3 Complex nized yeast was not affected by injection of antibodies
Recruitment to CR and FcR Phagosomes against MLCK [19]. However, this might be explained
by differences in the modes of action of MLCK antibod-J774.A1
ies and inhibitors and/or differences in the nature of
CR Recruitment (Percentage of Control)
the phagocytic targets that were used. Nonopsonized
Myosin-IIA F-Actin Arp2/3 Complex yeasts can be recognized by other phagocytic receptors
[20] that may induce different signaling pathways.Control 100 100 100
The requirement for myosin-II in CR-induced actinY-27632 49  10* 56  24** 56  9*
n  4 n  3 n  3 assembly is particularly intriguing, and we do not yet
ML7 39  11* 51  14** 38  17** understand its molecular basis. There is no striking ef-
n  4 n  6 n  4 fect of myosin-II inhibition on the general localization of
BDM [4] 34  22** 23  24** Arp2/3 complex in cells expressing the myosin-II mutant
n  6 n  5
GFP-N592 (see Figure S4A, where Arp2/3 complex and
FcR Recruitment (Percentage of Control) F-actin are typically enriched in the lamellipodia). How-
ever, myosin-IIA does colocalize with Arp2/3 complexMyosin-IIA F-Actin Arp2/3 Complex
and F-actin at early (stages 1–3) CR phagosomes (Fig-
Control 100 100 100 ure S4B). Thus, CR-mediated phagocytosis specifically
ML7 40  12* 122  33 93  7
uses myosin-II to assist in the assembly of actin cupsn  3 n  4 n  4
around particles. We do not think it likely that myosin-BDM n.d. [4] [4]
II is generally connected with Arp2/3 complex-mediated
Data are expressed as in Table 1.
actin assembly, but there may be other specific cellular
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Figure 3. Schematic Representation of CR and FcR Phagocytic Pathways
ROK and MLCK are important for myosin-IIA localization and activity leading to actin assembly and particle engulfment in CR phagocytosis.
In contrast, during FcR-mediated phagocytosis, actin assembly is independent of Rho, ROK, MLCK, and myosin-IIA. Rac and Cdc42 mediate
the actin assembly at FcR phagosomes possibly through the Fyb/SLAP protein, which appears to interact with Arp2/3 complex via WASp-
family proteins [28]. Our observations are shown in red. The numbers indicated on each pathway refer to published sources of the data (see
references).
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